In NFV, 50–70 % of patients are neuropathologically diagnosed as FTLD-tau, corresponding to corticobasal degeneration, progressive supranuclear palsy or Pick’s disease [9, 26, 39]. The gene discussed is MAPT; the disease is progressive supranuclear palsy.